UBS Raises Price Target on UnitedHealth Group (UNH) Following Investor Day
- Wall St slips as higher yields offset upbeat corporate earnings
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Boeing reports first revenue drop in 7 quarters as deliveries decline
- Oil prices fall as U.S. business activity cools, concerns over Middle East ease
- Yen on the brink, but Tesla pulls back
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Hasbro (HAS) brand strength sees earnings top expectations
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Wolfe Research Downgrades Warner Brothers Discovery (WBD) to Underperform, 'out of concern that an incipient advertising downturn put guidance at risk'
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
UnitedHealth Group (UNH) PT Raised to $182 at Jefferies
November 30, 2016 8:16 AM ESTJefferies analyst David Windley reiterated a Buy and raised his price target on UnitedHealth Group (NYSE: UNH) to $182.00 (from $168.00) following the company's analyst day yesterday.
Windley commented, "In case you didn't hear, UNH had a small get together Tuesday in NY highlighting... More
Leerink Partners Raises Price Target on UnitedHealth Group (UNH) to $195; Reiterates Outperform
November 30, 2016 7:46 AM ESTLeerink Partners reiterated an Outperform rating on UnitedHealth Group (NYSE: UNH), and raised the price target to $195.00 (from $185.00), following a company update. EPS guidance of $9.30 - $9.60 came in better than the Street expectation of $9.16. The EPS upside is driven by better than expected top-line growth in MA, and Optum as well as the ObamaCare tax holiday.
Analyst Ana Gupte, commented, "We remain bullish on UNH (OP) and reiterate our top pick status on the name while raising estimates and PT to $195. In addition to surprising meaningfully to the upside on 2017 guidance,... More
Mizuho Securities Upgrades UnitedHealth Group (UNH) to Buy
November 30, 2016 6:09 AM ESTMizuho Securities upgraded UnitedHealth Group (NYSE: UNH) from Neutral to Buy with a price target of $178.00.
Analyst Sheryl Skolnick commented, "Despite the still-uncertain politics of health care, we are raising our rating on UNH shares to Buy/$178 PT. UNH made a compelling... More
Walgreens Boots Alliance (WBA) on Watch as OptumRx (UNH) and CVS Pharmacy (CVS) Announce Partnership
November 29, 2016 9:33 AM ESTWalgreens Boots Alliance (NASDAQ: WBA) on watch after OptumRx and CVS Pharmacy (NYSE CVS) announced they are partnering to provide more convenient choices and lower costs for consumers and clients while improving health outcomes. OptumRx is UnitedHealth Group's (NYSE: UNH)... More
Pre-Open Stock Movers 11/29: (CYTR) (VBLT) (THO) Higher; (NVLS) (FOLD) (SCVL) Lower (more...)
November 29, 2016 9:18 AM ESTToday's Pre-Open Stock Movers
Nivalis Therapeutics (NASDAQ: NVLS) 53.6% LOWER; announced topline results from the Company's Phase 2 trial evaluating the efficacy and safety of two doses of cavosonstat, 200 mg and 400 mg, in adult patients with CF who had two copies of the F508del-CFTR mutation and were being treated with Orkambi. There were no dose limiting toxicities and cavosonstat was well tolerated at all doses in the trial. The trial failed, however, to demonstrate benefit in absolute change in percent predicted FEV1, the trials primary endpoint, or in sweat chloride reduction... More
Jefferies Remains Bullish on UnitedHealth Group (UNH) Following Conference Call
November 29, 2016 8:10 AM ESTJefferies reiterated a Buy rating and $168.00 price target on UnitedHealth Group (NYSE: UNH) following the company's 3Q earnings conference call.
Analyst David Windley commented, "CEO Hemsley's supportive comments of 2017 consensus on the 3Q16 earnings call foreshadowed a positive outlook. Considering that... More
Health stocks boost Wall Street; energy a drag
November 29, 2016 7:33 AM ESTBy Caroline Valetkevitch
(Reuters) - U.S. stocks edged higher on Tuesday as an upbeat outlook from UnitedHealth lifted health insurers, though a sharp drop in oil prices weighed on energy shares and limited the advance.
The day's small gains followed a decline in the market on Monday. Analysts said the post-U.S. election rally may be losing momentum, wit the S&P 500 now up roughly 8 percent for the year to date.
Wall Street has risen sharply following Donald Trump's White House win, helped in part by investor expectations that his plans to increase infrastructure spending,... More
After-Hours Stock Movers 09/01: (THO) (TIVO) (VNET) Higher; (NVLS) (FOLD) (SCVL) Lower (more...)
November 28, 2016 5:57 PM ESTToday's After-Hours Stock Movers
Nivalis Therapeutics (NASDAQ: NVLS) 53.6% LOWER; announced topline results from the Company's Phase 2 trial evaluating the efficacy and safety of two doses of cavosonstat, 200 mg and 400 mg, in adult patients with CF who had two copies of the F508del-CFTR mutation and were being treated with Orkambi. There were no dose limiting toxicities and cavosonstat was well tolerated at all doses in the trial. The trial failed, however, to demonstrate benefit in absolute change in percent predicted FEV1, the trials primary endpoint, or in sweat chloride reduction at 12... More
UnitedHealth Group (UNH) Issues FY17 Outlook Above the Street Ahead of Investor Day
November 28, 2016 4:18 PM ESTUnitedHealth Group (NYSE: UNH) will host its annual Investor Conference with analysts and institutional investors in New York City on Tuesday, November 29, 2016, beginning at 8:00 a.m. EST. At the meeting, senior leaders will discuss the Companys performance and outlook, including reviewing business trends and initiatives... More